Cancer Facts and Figures (2017). Atlanta GAC, Society. Estimated numbers of new cancer cases for 2017, excluding basal cell and squamous cell skin cancers and in situ carcinomas except urinary bladder, 2017
Rebbeck TR, Haas GP (2014) Temporal trends and racial disparities in global prostate cancer prevalence. Can J Urol 21(5):7496–7506
PubMed
PubMed Central
Google Scholar
Odedina FT, Ogunbiyi JO, Ukoli FAM (2006) Roots of prostate cancer in African-American men. J Natl Med Assoc 98(4):539–543
PubMed
PubMed Central
Google Scholar
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289
Article
Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Article
Google Scholar
Osegbe DN (1997) Prostate cancer in Nigerians: Facts and nonfacts. J Urol 157:1340–1343
Article
CAS
Google Scholar
Yarney J, Vanderpuye V, Mensah J (2013) Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men. Urol Oncol Semin Orig Investig 31:325–330
Google Scholar
Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F et al (2012) Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol 36(5):e271–e278. https://doi.org/10.1016/j.canep.2012.04.007
Article
PubMed
PubMed Central
Google Scholar
Kaboré FA, Zango B, Kambou T, Ouédraogo AS, Bambara A, Yaméogo C et al (2014) Prostate Cancer disease characteristics at the time of diagnosis and initial treatment offered in a tertiary hospital at Ouagadougou (Burkina Faso). Open J Urol 4(1):7–12. https://doi.org/10.4236/oju.2014.41002
Article
Google Scholar
Parkin DM, Bray F, Ferlay J, Jemal A (2014) Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev 23(6):953–966
Article
Google Scholar
Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F et al (2008) The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS Cohort Study. Eur Urol 53(1):99–105
Article
Google Scholar
Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR et al (2009) Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 4(Suppl 1):S2
Article
Google Scholar
Fleming ST, McDavid K, Pearce K, Pavlov D (2006) Comorbidities and the risk of late-stage prostate cancer. ScientificWorldJournal 6:2460–2470
Article
Google Scholar
Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A et al (2011) Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 117(10):2058–2066
Article
Google Scholar
Aiken WD, Jones KS, Ragin C, James K (2015) Rural-urban differences in the clinico-pathologic profiles of Jamaican men with prostate cancer. Infect Agent Cancer 10(1):32
Article
Google Scholar
Sritharan J, Demers PA, Harris SA, Cole DC, Peters CE, Villeneuve PJ et al (2017) Occupation and risk of prostate cancer in Canadian men: a case-control study across eight Canadian provinces. Cancer Epidemiol 48:96–103
Article
Google Scholar
Aizer AA, Chen M-H, McCarthy EP, Mendu ML, Koo S, Wilhite TJ et al (2013) Marital status and survival in patients with cancer. J Clin Oncol 31(31):3869–3876
Article
Google Scholar
Yaqub F (2013) When cancer strikes a friend. Lancet Oncol 14(4):296
Article
Google Scholar
Egevad L, Delahunt B, Srigley JR, Samaratunga H (2016) International Society of Urological Pathology (ISUP) grading of prostate cancer—an ISUP consensus on contemporary grading. APMIS 124(6):433–435
Article
Google Scholar
Gordetsky J, Epstein J (2016) Grading of prostatic adenocarcinoma: current state and prognostic implications. Diagn Pathol 11(1):2–9
Article
Google Scholar
Sobin L, Gospodariwicz M, Wittekind CE (2009) TNM Classification of malignant tumors. In: UICC International Union against Cancer, 7 ed. Wiley-Blackwell, Hoboken, pp 243–248
D’Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D et al (2001) Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 166(6):2185–2188
Article
Google Scholar
Pernar CH, Ebot EM, Wilson KM, Mucci LA (2018) The Epidemiology of prostate cancer. Cold Spring Harb Perspect Med 2018(8):a030361;1-12. https://doi.org/10.1101/cshperspect.a030361
Badal S, Aiken W, Morrison B, Valentine H, Bryan S, Gachii A et al (2020) Disparities in prostate cancer incidence and mortality rates: Solvable or not? Prostate 80(1):3–16
Article
Google Scholar
Tao Z-Q, Shi A-M, Wang K-X, Zhang W-D (2015) Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol Sci 19(5):805–812
PubMed
Google Scholar
Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB et al (2009) Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 101(18):1280–1283
Article
Google Scholar
Obiorah CC, Nwosu SO (2011) A histopathological study of carcinoma of the prostate in port Harcourt, Nigeria. Niger J Clin Pract 14(3):363–367
Article
CAS
Google Scholar
Le Roux HA, Urry RJ, Sartorius B, Aldous C (2015) Prostate Cancer at a regional hospital in South Africa: we are only seeing the tip of the iceberg. S Afr J Surg 53(3–4):57–62
PubMed
Google Scholar
Hosein I, Sukhraj R, Goetz L, Rambarran N, Persaud SA (2016) A clinicopathological profile of prostate cancer in Trinidad and Tobago. Adv Urol 2016;2075021. https://doi.org/10.1155/2016/2075021
Odubanjo MO, Banjo AAF, Ayoola S, Abdulkareem FB, Anunobi CC, Olayinka AA (2009) The clinicopathologic pattern of prostatic carcinoma in Lagos, Nigeria. N Am J Med Sci 6(2):71–75
Google Scholar
Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S et al (2003) Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology 61(5):987–992
Article
CAS
Google Scholar
Heyns CF, Fisher M, Lecuona A, van der Merwe A (2011) Prostate cancer among different racial groups in the western cape: Presenting features and management. S Afr Med J 101(4):267–270
Article
CAS
Google Scholar
Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie R-A, Segone AM et al (2014) Clinical presentation of prostate cancer in Black South Africans. Prostate 74(8):880–91
Article
CAS
Google Scholar
Chinedu OC, Vitalis O (2015) A population based study of prostate cancer in Rivers State. Nigeria Int J Biomed Sci 15(2):57–62
Google Scholar
Isiwele EM, Bassey I-AE, Ikpi EE, Enakirerhi GE, Otobo FO, Essiet A et al (2018) Histopathologic patterns of urological malignancies in Calabar, South-Southern Nigeria: a ten-year review. J Cancer Tumor Int 8(1):1–10
Article
Google Scholar
Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA (2006) African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer 107(1):75–82
Article
Google Scholar
Magoha GAO (2000) Management and survival in advanced prostate cancer in Nairobi. East Afr Med J 77(5):260–263
CAS
PubMed
Google Scholar
Health care quality in Africa: Uganda, Nigeria, Tanzania, Zambia, Kenya, Zimbabwe and South Africa|Aetna International [Internet]. 2020. https://www.aetnainternational.com/en/about-us/explore/living-abroad/culture-lifestyle/health-care-quality-in-africa.html
Rebbeck TR, Zeigler-Johnson CM, Heyns CF, Gueye SM (2011) Prostate cancer screening, detection and treatment practices, among Sub-Saharan African urologists. African J Urol 17(3):85–91
Article
Google Scholar
Heyns C (2008) Is prostate cancer more common and aggressive in African men? Afr J Urol 14:66–74
Article
Google Scholar
Oladimeji O, Bidemi Y, Olufisayo JA, Sola A (2010) Prostate cancer awareness, knowledge, and screening practices among older men in Oyo State. Nigeria Int Q Community Health Educ 30(3):271–286
Article
Google Scholar
Powell IJ, Bollig-Fischer A (2013) Minireview: the molecular and genomic basis for prostate cancer health disparities. Mol Endocrinol 27(6):879–891
Article
CAS
Google Scholar
Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z et al (2015) Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer. J Clin Oncol
Rebbeck TR, Devesa SS, Chang B-L, Bunker CH, Cheng I, Cooney K et al (2013) Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent. Prostate Cancer. 2013:560857
Article
Google Scholar
Fernandez P, de Beer PD, van der Merwe LD, Heyns CF (2010) Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men. S Afr Med J 100(11):741–745
Article
CAS
Google Scholar
Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA et al (2014) A genome-wide association study of prostate cancer in West African men. Hum Genet 133(5):509–521
Article
CAS
Google Scholar
Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM et al (2012) Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate Cancer 2012:1–8
Article
Google Scholar
Kumar NB, Yu D, Akinremi TO, Odedina FT (2009) Comparing dietary and other lifestyle factors among immigrant Nigerian men living in the US and indigenous men from Nigeria: Potential implications for prostate cancer risk reduction. J Immigr Minor Heal 11(5):391–399
Article
Google Scholar